The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
From the PresidentFull Access

Task Force Appointed to Address Psychologist-Prescribing Issues

APA is committed to putting an end to psychologists' bid to win prescription privileges throughout the United States, and as part of a strategy to focus that commitment, the Board of Trustees agreed with me at our June retreat to create a special component called the Presidential Task Force to Review the Psychologist Prescribing Issue.

At the time of the retreat, Louisiana had just passed a psychologist-prescribing law—the second in the nation—and we anticipated that 2005 would see a flurry of similar legislation in several states. We resolved that such a law should not pass elsewhere.

Members of other medical specialties told us at our retreat that psychiatry is not alone in confronting assaults on safe patient care and that, to date, APA has done laudable work to halt attempts by psychologists to gain prescribing rights. But they also confirmed our forecast for 2005: With two state victories behind them, psychologists will fight for prescribing privileges in even more states.

The Board recognized that a task force would be a key step toward reinforcing and intensifying APA's advocacy on scope-of-practice and related patient safety issues—top priorities for us then, now, and in 2005 and beyond. And so the Presidential Task Force to Review the Psychologist Prescribing Issue was formed.

The task force has been charged with providing the Board with comprehensive short- and long-range strategies to address our scope-of-practice and patient safety concerns, and it will provide a report to the Board in December. These are the members of the task force:

Chair: Allan Tasman, M.D., of Kentucky. Dr. Tasman is a past president of APA (1999-2000) and serves as chair of the Executive and Officer Compensation Committee, a member of the Finance and Budget Committee, and a member of the Council on Global Psychiatry. Dr. Tasman has held several other leadership roles in APA components, the World Psychiatric Association, and other prominent organizations.

Harold Eist, M.D., of Maryland. Dr. Eist is a past president of APA (1996-97) and, among other leadership positions, recently chaired the Council on Global Psychiatry. He also served twice as president of the Washington Psychiatric Society.

Barbara Gard of California. Ms. Gard is the executive director of the California Psychiatric Association (CPA) and has provided much experience and thoughtful leadership to CPA regarding psychologists' prescribing attempts in California.

Patrice Harris, M.D., of Georgia. Dr. Harris serves on several APA components, including as an alternate in the APA delegation to the AMA and as an APAPAC board member. Dr. Harris is vice president of the Georgia Psychiatric Physicians Association and a past trustee-at-large of APA.

Karen Lynne Moritz, M.D., of Missouri. Dr. Moritz has served in the APA delegation to the AMA and on the Committee on Private Practice. She also served as legislative representative for Eastern Missouri Psychiatric Society.

Rodrigo Muñoz, M.D., of California. Dr. Muñoz is a past president of APA (1998-99) and chairs the Council on Global Psychiatry. He also serves in the APA delegation to the AMA and has held other leadership posts.

Robert Pyles, M.D., of Massachusetts. Dr. Pyles represents the Massachusetts Psychiatric Society in the APA Assembly. He also served on the Joint Commission on Government Relations, a former APA component whose responsibilities now fall under the Council on Advocacy and Public Policy.

The task force, as you may have already heard through other communication channels, is seeking your advice and consultation. Dr. Tasman and his team are interested in knowing what—in addition to the hard work that APA has already done—you think must be done locally and nationally, the resources it will take, and your ideas about strategy, both short and long term. Please e-mail your confidential comments to Dr. Tasman at or write to him at this address: Allan Tasman, M.D., Professor and Chair, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Ky. 40292.

As I wrote in this space before, fighting to protect our patients “is a marathon with many sprints. Specialty by specialty, state by state, year by year, bill by bill, we must advocate for our patients. Every district branch and state association must prepare for a sustained, multifront effort.”

All of this is to underscore that we need your help, input, and support at this critical time. Psychologists are determined, and—for our patients' sake—we must be determined more so.

APA is committed to maintaining and improving the quality of care our patients receive. With your help, the task force—along with the Board, the Assembly, the staff, and indeed, the entire Association—will succeed in positioning APA for victory for our patients in 2005 and beyond. ▪